Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
personal electronic medical record · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Case | EXPERIMENTAL | Assigned a Personal Electronic Health Record |
| Control: Usual Care | ACTIVE_COMPARATOR | Assigned to control arm, continued to receive care as usual in community. Was issued information on community health resources, but did not use research study personal health record. |
| Name | Type | Description |
|---|---|---|
| personal electronic medical record | OTHER | - |
Inclusion Criteria: 1. Currently in treatment at the CMHC. 2. Serious Mental Illness: based on or chart review; 3. One or more Chronic Medical Condition as ascertained via administrative records.
The personal electronic medical record is used for chronic comorbid conditions, which are the simultaneous presence of two or more chronic diseases in a patient. It is an investigational product being studied in a Phase 3 clinical trial to assess its potential role in managing these conditions.
The personal electronic medical record is being developed by National Healthcare Corp. (ticker: NHC). The company is conducting a Phase 3 clinical trial to evaluate this product for chronic comorbid conditions.
The personal electronic medical record is in Phase 3 clinical development. It is an investigational product and has not been approved by regulatory authorities. One Phase 3 trial has been completed, with 170 participants enrolled.
The personal electronic medical record has one completed Phase 3 clinical trial, identified as NCT01724125, titled "An Electronic Personal Health Record for Mental Health Consumers." The trial enrolled 170 participants in the United States and studied the product for chronic comorbid conditions.
Yes, the Phase 3 clinical trial for the personal electronic medical record is randomized and active-controlled. The trial was not double-blinded, and it enrolled 170 participants aged 18 years and older in the United States.